Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142355 |
| CAS No | NA |
| Mol.F. | C14H18N2O3 |
| Mol.Wt. | 262.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142356 |
| CAS No | NA |
| Mol.F. | C12H14N2O5 |
| Mol.Wt. | 266.25 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142357 |
| CAS No | NA |
| Mol.F. | C13H15N3O4 |
| Mol.Wt. | 277.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142358 |
| CAS No | NA |
| Mol.F. | C14H16FN3O4 |
| Mol.Wt. | 309.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142359 |
| CAS No | NA |
| Mol.F. | C16H18N2O3 |
| Mol.Wt. | 286.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142360 |
| CAS No | NA |
| Mol.F. | C16H14N2O3 |
| Mol.Wt. | 282.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142361 |
| CAS No | NA |
| Mol.F. | C16H10N2O4 |
| Mol.Wt. | 294.27 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142362 |
| CAS No | NA |
| Mol.F. | C17H16N2O3 |
| Mol.Wt. | 296.33 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142363 |
| CAS No | NA |
| Mol.F. | C33H30N4O5 |
| Mol.Wt. | 562.63 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142364 |
| CAS No | NA |
| Mol.F. | C16H14N2O6S |
| Mol.Wt. | 362.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142365 |
| CAS No | NA |
| Mol.F. | C16H14N2O6S |
| Mol.Wt. | 362.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142366 |
| CAS No | NA |
| Mol.F. | C20H15F7N2O4 |
| Mol.Wt. | 480.34 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142367 |
| CAS No | NA |
| Mol.F. | C23H20F7N5O4 |
| Mol.Wt. | 563.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142368 |
| CAS No | NA |
| Mol.F. | C24H24F7N5O5 |
| Mol.Wt. | 595.47 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142369 |
| CAS No | NA |
| Mol.F. | C4H7ClN4O3 |
| Mol.Wt. | 194.58 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142370 |
| CAS No | NA |
| Mol.F. | C11H12FN5O3 |
| Mol.Wt. | 281.25 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |